#1 Clinical Trials Search in Europe

Mesna

Mesna, also known as sodium 2-mercaptoethanesulfonate, is a drug that has been the subject of several clinical trials for its potential use in treating various medical conditions. These trials aim to explore Mesna’s effectiveness in areas such as obesity management, kidney protection, cancer treatment, and more. This article provides an overview of the ongoing research and potential applications of Mesna in different medical fields.

Table of Contents

What is MESNA?

MESNA, which stands for sodium 2-mercaptoethanesulfonate, is a medication used primarily to protect the bladder from the harmful effects of certain chemotherapy drugs. It’s also known by other names such as Mesnex[1]. MESNA was initially approved as a mucolytic agent, which means it helps break down mucus in the respiratory system[2]. However, its main use today is in cancer treatment to prevent a side effect called hemorrhagic cystitis, which is bleeding in the bladder caused by some chemotherapy medications.

How MESNA Works

MESNA works by breaking down harmful substances that can damage the lining of the bladder. When certain chemotherapy drugs, particularly cyclophosphamide and ifosfamide, are broken down by the body, they produce toxic byproducts that can irritate and damage the bladder. MESNA binds to these harmful byproducts and makes them less toxic, thereby protecting the bladder[3].

One important characteristic of MESNA is that it’s quickly eliminated from the body through the kidneys. This rapid elimination means that MESNA can effectively protect the bladder without interfering with the cancer-fighting effects of chemotherapy in other parts of the body[2].

Medical Conditions Treated with MESNA

MESNA is primarily used in conjunction with chemotherapy treatments for various types of cancer. Some of the conditions where MESNA might be used include:

  • Various types of cancer: MESNA is often used alongside chemotherapy drugs like cyclophosphamide and ifosfamide in the treatment of different cancers[4].
  • Ewing’s Sarcoma: A type of bone cancer where MESNA is used to protect against the side effects of chemotherapy[5].
  • Multiple Sclerosis: In some experimental treatments for multiple sclerosis, MESNA is used to protect against the side effects of high-dose chemotherapy[6].
  • Kidney transplantation: MESNA is sometimes used in protocols for kidney transplantation to protect against the side effects of certain medications used in the transplant process[1].

How MESNA is Administered

MESNA is typically given in conjunction with chemotherapy treatments. It can be administered in several ways:

  • Intravenous (IV) injection: MESNA is often given directly into a vein through an IV line[3].
  • Oral tablets: In some cases, MESNA may be given as tablets to be taken by mouth[3].
  • Continuous infusion: Sometimes, MESNA is given as a continuous infusion over several hours[1].

The dosage and schedule of MESNA administration depend on the specific chemotherapy regimen being used. Typically, MESNA is given before, during, and after the chemotherapy drug that it’s protecting against[3][1].

Potential Side Effects

While MESNA is generally well-tolerated, like all medications, it can have some side effects. These may include:

  • Nausea or vomiting
  • Headache
  • Diarrhea
  • Fatigue
  • Allergic reactions (in rare cases)

It’s important to note that many of these side effects are also common with chemotherapy treatments, so it can be difficult to distinguish which symptoms are caused by MESNA and which are from the chemotherapy itself[5].

Ongoing Research and Clinical Trials

Researchers continue to study MESNA to understand its full potential in medical treatments. Some areas of ongoing research include:

  • Kidney protection: Studies are investigating whether MESNA can help protect the kidneys from damage in various medical conditions[7].
  • Pleural adhesiolysis: Research is being conducted on using MESNA to break down adhesions in the lungs, which can occur in some lung conditions[8].
  • Temporomandibular joint disorders: Some studies are looking at whether MESNA injections could help in treating certain jaw joint problems[2].

These research areas show that while MESNA is primarily used in cancer treatment today, it may have potential applications in other areas of medicine in the future.

Condition Mesna Application Key Findings/Objectives
Obesity Oral administration Investigating effects on plasma total cysteine concentrations
Chronic Renal Insufficiency Intravenous administration Potential prevention of contrast-induced nephropathy
End-Stage Renal Disease Intravenous administration Examining effects on homocysteine removal during hemodialysis
Implant Capsular Contracture Surgical application Assisting in capsulectomy procedures
Prostate Cancer Combination with Ifosfamide Evaluating efficacy and safety in metastatic castration-resistant cases
TMJ Internal Derangement Intra-articular injection Comparing with arthrocentesis for treatment effectiveness
Chemotherapy-induced Side Effects Intravenous administration Prevention of doxorubicin-induced plasma protein oxidation
Soft Tissue Sarcoma Combination with other therapies Assessing as part of neoadjuvant therapy

FAQ

  • What is Mesna and how does it work? Mesna is a drug also known as sodium 2-mercaptoethanesulfonate. It works by breaking down disulfide bonds between polypeptide chains, which can help in various medical applications such as reducing mucus in respiratory conditions or protecting against certain chemotherapy side effects.
  • In which medical conditions is Mesna being studied? Mesna is being studied in various conditions including obesity, kidney protection during contrast agent use, end-stage renal disease, prostate cancer, temporomandibular joint disorders, and as a protective agent during chemotherapy for cancer patients.
  • How is Mesna being used in obesity research? In obesity research, Mesna is being studied for its potential to lower plasma total cysteine concentrations. A clinical trial is investigating the effects of single ascending doses of oral Mesna on plasma cysteine levels in overweight or obese participants.
  • Can Mesna help protect the kidneys? Yes, Mesna is being studied for its potential to protect the kidneys. It's being investigated as a preventive measure against contrast-induced nephropathy in patients with chronic renal insufficiency who are receiving contrast media for medical procedures.
  • Is Mesna used in cancer treatment? Mesna is used in cancer treatment, primarily as a protective agent. It's often given alongside chemotherapy drugs like ifosfamide to prevent side effects such as hemorrhagic cystitis. It's also being studied in combination with other drugs for treating various types of cancer, including soft tissue sarcomas.

Ongoing Clinical Trials on Mesna

  • Study of Brexucabtagene Autoleucel in Patients with Relapsed or Refractory Mantle Cell Lymphoma

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    France Germany The Netherlands Spain

  • Study on Brexucabtagene Autoleucel for Adults with Relapsed/Refractory Hairy Cell Leukemia

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Austria France Germany Italy The Netherlands Spain +1

  • Study on Brexucabtagene Autoleucel for Adults with Relapsed or Refractory Burkitt Lymphoma

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Austria France Germany Italy The Netherlands Spain +1

  • Study on Brexucabtagene Autoleucel for Adults with Relapsed/Refractory Waldenstrom Macroglobulinemia Using a Drug Combination

    Not recruiting

    1 1 1
    Investigated drugs:
    Austria France Germany Italy The Netherlands Spain +1

  • Study on Brexucabtagene Autoleucel for Adults with Relapsed/Refractory Richter Transformation (RT)

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Austria France Germany Italy The Netherlands Spain +1

Glossary

  • Mesna: A drug also known as sodium 2-mercaptoethanesulfonate, used to prevent side effects of certain chemotherapy drugs and being studied for various other medical applications.
  • Cysteine: An amino acid found in the blood that has been associated with obesity in some studies.
  • Contrast-induced nephropathy: A form of kidney damage that can occur after the use of certain contrast agents in medical imaging procedures.
  • Pharmacokinetics: The study of how a drug is absorbed, distributed, metabolized, and eliminated by the body.
  • Pharmacodynamics: The study of the biochemical and physiological effects of drugs on the body.
  • Homocysteine: An amino acid in the blood that, at elevated levels, may increase the risk of heart disease and stroke.
  • End-stage renal disease: The last stage of chronic kidney disease where the kidneys no longer function well enough to meet the needs of daily life.
  • Hemodialysis: A treatment for kidney failure that uses a machine to filter waste and excess fluids from the blood.
  • Temporomandibular joint (TMJ) disorder: A condition affecting the jaw joint and surrounding muscles, often causing pain and difficulty in jaw movement.
  • Arthrocentesis: A minimally invasive procedure to remove fluid from a joint space for diagnostic or therapeutic purposes.
  • Doxorubicin: A chemotherapy drug used to treat various types of cancer.
  • Ifosfamide: A chemotherapy drug often used in combination with other medications to treat certain types of cancer.
  • Soft tissue sarcoma: A type of cancer that develops in soft tissues such as muscles, tendons, and blood vessels.

References

  1. https://clinicaltrials.gov/study/NCT02029638
  2. https://clinicaltrials.gov/study/NCT05882604
  3. https://clinicaltrials.gov/study/NCT00578539
  4. https://clinicaltrials.gov/study/NCT00061893
  5. https://clinicaltrials.gov/study/NCT02212574
  6. https://clinicaltrials.gov/study/NCT00040482
  7. https://clinicaltrials.gov/study/NCT00286403
  8. https://clinicaltrials.gov/study/NCT03172052